NCT02728830 2024-02-21
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Duke University
Phase EARLY_PHASE1 Completed
Duke University
Kaiser Permanente
Hoosier Cancer Research Network
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences